MCD vs WHWK · P/E 23, rev $25.92B vs $202.8M cap
McDonald’s Corporation (MCD) versus Whitehawk Therapeutics, Inc. (WHWK) — a side-by-side from cached financials, not a winner call.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Latest reported WHWK revenue for 2026-06-30 was $0. Net income was -$38.8M. WHWK currently screens at market cap $202.8M.
MCD currently screens at market cap $201.66B and trailing P/E 23.4. WHWK currently screens at market cap $202.8M.
Not investment advice. Open the MCD and WHWK stock pages for the full models.
Not investment advice.